Key Takeaways
- • Bain Capital is positioned as a leading bidder for an $800+ million radiology/diagnostic imaging business acquisition, signaling continued aggressive healthcare investment activity by the Boston-based PE firm in 2026.
- • The deal reflects sustained private equity interest in diagnostic imaging assets, with healthcare PE activity remaining steady through 2025-2026, including approximately a dozen-plus deals in the diagnostic imaging sector alone.
- • Bain Capital's healthcare investment track record includes recent major acquisitions in healthcare technology (HealthEdge at $2.6 billion valuation) and value-based care platforms (InnovaCare Health), demonstrating a multi-pronged strategy across care delivery, software, and diagnostics.
- • The radiology business acquisition would add diagnostic imaging capabilities to Bain Capital's growing healthcare portfolio, complementing existing investments in primary care networks and healthcare IT solutions.
- • Competitive bidding for the asset may include other PE firms, with prior Infratil diagnostic imaging auction processes (Qscan) attracting multiple bidders including Pacific Equity Partners and Bain Capital.
Summary
Bain Capital is advancing toward acquisition of a major radiology and diagnostic imaging business valued at over $800 million, according to reporting from The Australian. The Boston-based private equity firm has emerged as a front-runner bidder in what represents another significant healthcare consolidation opportunity within a sector experiencing sustained PE investment activity.
The transaction reflects broader momentum in healthcare private equity during 2025-2026, with diagnostic imaging representing a particularly active subsector. Industry data indicates approximately a dozen or more PE-backed deals in diagnostic imaging occurred during this period, underscoring consistent institutional appetite for consolidation of fragmented radiology and imaging service providers. Bain Capital's pursuit of this asset aligns with the firm's demonstrated strategy of building integrated healthcare platforms through strategic acquisitions.
Bain Capital has substantially expanded its healthcare footprint in recent years through high-profile acquisitions. Most notably, the firm announced a $2.6 billion acquisition of HealthEdge, a leading healthcare technology and software platform, in a definitive agreement. Additionally, Bain Capital secured a majority investment stake in InnovaCare Health, a value-based healthcare provider based in Lake Nona, Florida, which operates an integrated primary care network serving over 250,000 patients annually alongside support for physicians managing approximately 27,000 Medicare Advantage members. Under that investment structure, founder and CEO Dr. Richard Shinto and the existing management team retained significant ownership alongside Bain Capital and co-investor Summit Partners.
The radiology acquisition would complete a healthcare ecosystem strategy encompassing care delivery infrastructure (InnovaCare), healthcare software and administration (HealthEdge), and now diagnostic imaging services. This vertical integration approach allows Bain Capital to capture multiple value-creation levers across the healthcare value chain while positioning portfolio companies for cross-selling and operational synergies. Competitive tension in this particular auction process may emerge from other PE firms active in healthcare imaging, though Bain Capital's established healthcare expertise and capital base position it competitively for a deal of this magnitude.
The transaction reflects broader momentum in healthcare private equity during 2025-2026, with diagnostic imaging representing a particularly active subsector. Industry data indicates approximately a dozen or more PE-backed deals in diagnostic imaging occurred during this period, underscoring consistent institutional appetite for consolidation of fragmented radiology and imaging service providers. Bain Capital's pursuit of this asset aligns with the firm's demonstrated strategy of building integrated healthcare platforms through strategic acquisitions.
Bain Capital has substantially expanded its healthcare footprint in recent years through high-profile acquisitions. Most notably, the firm announced a $2.6 billion acquisition of HealthEdge, a leading healthcare technology and software platform, in a definitive agreement. Additionally, Bain Capital secured a majority investment stake in InnovaCare Health, a value-based healthcare provider based in Lake Nona, Florida, which operates an integrated primary care network serving over 250,000 patients annually alongside support for physicians managing approximately 27,000 Medicare Advantage members. Under that investment structure, founder and CEO Dr. Richard Shinto and the existing management team retained significant ownership alongside Bain Capital and co-investor Summit Partners.
The radiology acquisition would complete a healthcare ecosystem strategy encompassing care delivery infrastructure (InnovaCare), healthcare software and administration (HealthEdge), and now diagnostic imaging services. This vertical integration approach allows Bain Capital to capture multiple value-creation levers across the healthcare value chain while positioning portfolio companies for cross-selling and operational synergies. Competitive tension in this particular auction process may emerge from other PE firms active in healthcare imaging, though Bain Capital's established healthcare expertise and capital base position it competitively for a deal of this magnitude.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.